+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Edema"

From
Retinal Biologics Global Market Report 2024 - Product Thumbnail Image

Retinal Biologics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Retinal Disorder Treatment Global Market Report 2024 - Product Thumbnail Image

Retinal Disorder Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Ophthalmic Medical Lasers Global Market Report 2024 - Product Thumbnail Image

Ophthalmic Medical Lasers Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

Macular Edema is a condition in which fluid accumulates in the macula, the central part of the retina responsible for sharp, central vision. It is a common complication of diabetes, and can also be caused by other diseases or conditions such as uveitis, retinal vein occlusion, and retinopathy of prematurity. Treatment options for macular edema include laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments for macular edema include laser photocoagulation, which uses a laser to reduce the amount of fluid in the macula. Intravitreal injections are also used to reduce fluid accumulation, and vitrectomy is a surgical procedure that removes the vitreous gel from the eye and replaces it with a gas bubble. Companies in the macular edema market include Regeneron Pharmaceuticals, Allergan, Novartis, Roche, and Bayer. Show Less Read more